> The NHS is going to tell them to get bent, that they're paying the agreed upon price for the act and don't care about the rest of their bullshit, and if they're not happy with it they can close their office.
The Canadian system has socialized insurance plus price controls. But those are two separate things—you can have one without the other. The Swiss system, for example, has price schedules, but not “socialized” medicine.
As to drug pricing: you’re repeating FUD about Medicare. What should clue you in that this is FUD is that, for the most part, Medicare itself doesn’t cover prescription drugs. (Only drugs you get during a hospital visit.) Prescription drugs are covered by an optional program called Medicare Part D, which is provided through private insurance. So yes, the Secretary of DHHS isn’t permitted to negotiate prescription drug prices for Medicare. That’s because that’s the role of the Prescription Drug Plans under Part D. The private insurance plans that are offered under Part D do negotiate drug prices. See: https://fas.org/sgp/crs/misc/IF11318.pdf
> Determination of Drug Prices in Medicare Part D
To bolster market competition and limit the federal role, the MMA included a non-interference provision (Social Security Act (SSA) §1860D-11(i)), which states that in carrying out the requirements of the Part D program, “the Secretary: (1) may not interfere with the negotiations between drug manufacturers and pharmacies and PDP sponsors; and (2) may not require a particular formulary or institute a price structure for the reimbursement of covered part D drugs.”
> Part D sponsors, working with pharmacy benefit managers (PBMs), negotiate prices with drug manufacturers and contract with pharmacies to dispense drugs to plan enrollees. Negotiated price concessions mainly take the form of rebates (after-sale reductions) from a manufacturer’s list price for brand-name drugs.